Doctor Nikita Ermolaev
Medical University of Vienna, Vienna (Austria)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
Potential hematopoietic effects of SGLT2 inhibitors in patients with cardiac amyloidosis.
Event: ESC Congress 2024
Topic: Cardiovascular Disease in the Elderly
Session: Primary care for the elderly patient: practical aspects
Cardiopulmonary exercise testing in correlation with magnetic resonance imaging in patients with cardiac amyloidosis
Event: ESC Preventive Cardiology 2024
Topic: Spiroergometry
Session: The power of exercise testing for cardiovascular risk assessment
